ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
ATOSSA THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.56−0.35 (-12.03%)
Close on Oct 19, 2026
- Market cap
- $22.81M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Atossa Therapeutics has not reported a dividend
No dividend per share appears in Atossa Therapeutics's annual filings since fiscal 2010.